CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 51 enrolled
Drug / intervention
70% v/v Isopropyl Alcohol Surgical Solution +1 moredrug
Likely dose
2%w/v Chlorhexidine Gluconate / 70% v/v Isopropyl Alcoholfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04756804
NCT04756804Phase 3Completed

A Randomized, Controlled Clinical Trial Evaluating A Novel Perioperative Patient Skin Antiseptic Preparation

Zurex Pharma, Inc.·interventional·Posted Feb 16, 2021·Updated Mar 20, 2024

In Brief

A Phase 3 clinical trial evaluating 70% v/v Isopropyl Alcohol Surgical Solution and 2%w/v Chlorhexidine Gluconate / 70% v/v Isopropyl Alcohol for Surgical Site Infection. Completed, enrolled 51 participants across 1 site.

Detailed Summary

This study will evaluate a new topical skin antiseptic perioperative preparation and the standard of care to determine efficacy on the rates of surgical site infections of surgical patients. Safety will also be assessed.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
202120222023202420252026
First PostedFeb 16, 2021
Enrollment StartJun 21, 2021
Primary CompletionSep 29, 2022
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 5.4 years ago

Interventions

70% v/v Isopropyl Alcohol Surgical Solutiondrug

Patient preoperative skin preparation

2%w/v Chlorhexidine Gluconate / 70% v/v Isopropyl Alcoholdrug

Patient preoperative skin preparation